Monopar Therapeutics (MNPR) surges 20% pre-market after entering exclusive agreement with Alexion, AstraZeneca for Wilson ...

Sino-America clinical-stage biotech Eccogene announced that it will receive a $60 million payment from AstraZeneca, which is ...

Monopar Therapeutics' market value nearly tripled Thursday after the biotechnology company agreed to license a treatment for patients with a rare genetic condition from AstraZeneca unit Alexion.

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

AstraZeneca, a global biopharmaceutical company that develops and commercializes prescription medicines, became a household ...

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune ...

The CHMP recommends approval for AZN's Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated ...

Monopar Therapeutics shares rose after the biotechnology company agreed to license a treatment for patients with a rare genetic condition from AstraZeneca unit Alexion. Shares of the Wilmette, Ill., ...

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

AstraZeneca’s share price has fallen 11%, leaving it looking even more of a bargain to me than before, supported by strong ...

Atrial fibrillation is a key risk factor for ischaemic stroke. Furthermore, patients with atrial fibrillation and stroke tend ...

Vanguard Renewables held a groundbreaking ceremony for its newest renewable natural gas project at The Moyer Family’s ...